Indian stocks: Visit www.stage2stocks.com →

PMV Pharmaceuticals, Inc.

Stage 2 · Advancing · week 6

As of Oct 22, 2026, PMV Pharmaceuticals is in Stage 2, the uptrend phase, now in week 6 (since Sep 16, 2026). It closed at $1.31, 27.5% below its 52-week high and above its 200-day average, which is rising.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. More about the company

$1.31
-4.04% today
$98.5M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is PMVP early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 16w
S4 25w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 2w → S2 4w → S3 3w → S4 13w → S1 3w → S4 13w → S1 9w → S4 16w → S1 10w → S4 25w → S1 7w → S2 10w → S3 13w → S4 6w → S1 5w → S2 5w → S3 2w → S4 11w → S1 3w → S2 5w current
Total tracked: 165 weeks across 20 stage runs.

PMVP among Biotechnology232nd of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…232PMVPStage 2 · wk 643−4.7%
vs 52W High
-27.5%
$1.02 lo$1.80 hi
27.5% below 52W high, far from high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 6
1w13w26w
Week 6, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
0.5%
200 DMA: $1.30 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.17x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-4.7%
3M
+5.2%
6M
-8.7%
YTD
+6.1%
1Y
-14.7%
Scan Membership
Breakout Watch
Latest: 2023-08-31
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 6 · Vol 0.17x
2026-10-21S2
Wk 6 · Vol 0.29x
2026-10-20S2
Wk 5 · Vol 0.47x
2026-10-19S2
Wk 5 · Vol 0.26x
2026-10-16S2
Wk 5 · Vol 0.48x
2026-10-15S2
Wk 5 · Vol 0.51x
2026-10-14S2
Wk 5 · Vol 0.72x
2026-10-13S2
Wk 4 · Vol 0.71x
2026-10-12S2
Wk 4 · Vol 0.53x
2026-10-09S2
Wk 4 · Vol 1.19x
2026-10-08S2
Wk 4 · Vol 0.62x
2026-10-07S2
Wk 4 · Vol 0.81x
Moving averages & range
50 DMA
$1.38
200 DMA
$1.30
52W High
$1.80
52W Low
$1.02
5D Low
$1.21
Resistance levels (recent highs)
20d High
$1.79
60d High
$1.79
120d High
$1.79
250d High
$1.80
Next resistance
+37.2%
to 20d High
ROE
-70.9%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 1.0

PMV Pharmaceuticals: quick answers

What stage is PMV Pharmaceuticals in?

As of Oct 22, 2026, PMV Pharmaceuticals (PMVP) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 16, 2026 and is in week 6. What the four stages mean

Is PMV Pharmaceuticals in an uptrend?

Yes. PMV Pharmaceuticals is in a Stage 2 uptrend. It trades 0.5% above its 200-day average, which is rising.

How far is PMV Pharmaceuticals from its 52-week high?

PMV Pharmaceuticals closed at $1.31 on Oct 22, 2026, 27.5% below its 52-week high of $1.80. Its 52-week low is $1.02.

How has PMV Pharmaceuticals performed over the past year?

As of Oct 22, 2026, PMV Pharmaceuticals is down 14.7% over the past year and up 6.1% so far in 2026.

Which sector and industry is PMV Pharmaceuticals in?

PMV Pharmaceuticals is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.